Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation
Context: Dramatic increases in pharmaceutical merger and acquisition (M&A) activity since 2010 suggest we are in the midst of a third wave of industry consolidation.Methods: The authors reviewed 168 economic, legal, medical, industry, and government sources to examine the effects of consolidation on competition and innovation and to explore how industry attributes complicate M&A regulation in a pharmaceutical context.Findings: The authors find that, in spite of certain metrics that might argue otherwise, consolidation consistently reduces innovation and harms the public good. They also find that several factors within the pharmaceutical industry impede proper evaluation of proposed mergers. Because consumer choice across substitutes is limited, pharmaceutical markets frustrate conventional methods of defining markets. Volume bargaining in the pharmaceutical supply chain and asset managers’ common ownership of pharmaceutical firms further complicate the definitional process. Hence, the Herfindahl-Hirschman Index (HHI), one measure used by the Federal Trade Commission and the Department of Justice to screen for concerning M&A activity, sometimes depends on faulty market definitions and fails to capture the implications of consolidation for future market share.Conclusions: The authors describe ways to improve how pharmaceutical markets are defined, highlight quantitative alterations to HHI to account for common ownership, and propose areas requiring further research
Year of publication: |
2022
|
---|---|
Authors: | Feldman, Robin ; Fulton, Brent ; Godwin, Jamie ; Scheffler, Richard M |
Publisher: |
[S.l.] : SSRN |
Saved in:
freely available
Extent: | 1 Online-Ressource (25 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: Journal of Health Politics, Policy and Law, Vol. 47, No. 5, 2022: 583-607 Nach Informationen von SSRN wurde die ursprĂĽngliche Fassung des Dokuments 2022 erstellt |
Other identifiers: | 10.2139/ssrn.3921336 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10014244424
Saved in favorites
Similar items by person
-
State Actions to Promote and Restrain Commercial Accountable Care Organizations
King, Jaime S., (2020)
-
Social Capital and Health: A Concept whose Time has Come
Scheffler, Richard M, (2014)
-
Scheffler, Richard M, (2023)
- More ...